SYN News and Press, Synthetic Biologics Inc. From 04/13/21

Biotech Stocks Continue to Lead the Market in Early April 2021 With penny stocks, and specifically biotech penny stocks, there are a few reasons why popularity has increased this year. One of the main factors is the accessibility of trading with platforms like Robinhood and WeBull. This...

Cheap Penny Stocks On Robinhood Are Hard To Come By Buying penny stocks on Robinhood has become the norm for many traders. Given the app’s easy set-up and clear-cut operating platform, millions of new retail traders have made it their go-to platform. I know there’ve be...

Synthetic Biologics (SYN) has commenced enrollment and six study participants were dosed in a Phase 1a single-ascending dose clinical trial of SYN-020 intestinal alkaline phosphatase.The Phase 1a study is designed to evaluate safety, tolerability and pharmacokinetics of four single-ascen...

Synthetic Biologics Announces First Six Participants Dosed in Phase 1a Clinical Trial of SYN-020 Intestinal Alkaline Phosphatase A Multiple-Ascending Dose Study is on Track to Begin in Q3 2021 Phase 1 Clinical Program Intended to Support Development of SYN-020 in Multiple In...

Today, we take our first look at a small developmental company called Synthetic Biologics whose stock trades for less than a buck a share. The company has a couple of candidates in its pipeline and recently addressed its funding needs through 2023. A full analysis is presented in ...

Penny Stocks To Buy On Robinhood Under $1 In this article, we’ll discuss a few things. First, what are penny stocks , and second why would anyone want to buy them? I’ll also discuss a few popular penny stocks that have begun trending among Robinhood traders. Many of th...

Penny Stocks To Watch For March 2021 If You Like The Biotech Sector As we approach the third week of March, penny stocks seem to be on a hot streak. This is a combination of the massive decline in covid cases and the $1.9 trillion stimulus package passing. Also, investors’ fear a...

Synthetic Biologics, Inc. (SYN) Q4 2020 Earnings Conference Call March 4, 2021 04:30 pm ET Company Participants Vincent Perrone - Director, Corporate Communication Steve Shallcross - Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary, Director Mike Kaleko - Senior Vice ...

Synthetic Biologics (SYN): FY GAAP EPS of -$0.66 misses by $0.10.Cash and cash equivalents on December 31, 2020 were $6.2 million, a decrease of $8.8 million from December 31, 2019.Press Release For further details see: Synthetic Biologics EPS misses by $0.10

Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results -- Announced Washington University Has Begun Screening Patients for Enrollment in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients -- ...